Latest News - Acquisitions/Mergers

Tuesday, March 14, 2017 | Acquisitions/Mergers, Allergan

Allergan and Editas Medicine Enter Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

Allergan and Editas Medicine, a genome editing company, announced that Allergan's wholly owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a s…

Read the full story

Friday, March 10, 2017 | Acquisitions/Mergers

Amring Pharmaceuticals Acquired Six ANDAs

Generic drug company Amring Pharmaceuticals announced that it acquired six ANDAs from Luitpold Pharmaceuticals and AlphaForce, LLP, a joint venture between Luitpold Pharmaceuticals and Alphagen Labora…

Read the full story

Thursday, March 02, 2017 | Acquisitions/Mergers

Guardion Health Sciences Signs Letter of Intent to Acquire VectorVision

Guardion Health Sciences has signed a letter of intent to acquire VectorVision in a stock exchange transaction. VectorVision is a provider of standardized vision testing, and a leader in the fie…

Read the full story

Monday, February 27, 2017 | Acquisitions/Mergers, Abbott Medical Optics, AMO, Johnson & Johnson Vision Care

Johnson & Johnson Completes Acquisition of Abbott Medical Optics

Johnson & Johnson announced that it has completed the acquisition of Abbott Medical Optics (AMO) in an all-cash deal worth $4.325 billion. The deal, which was originally announced September 16, 20…

Read the full story

Tuesday, February 21, 2017 | Acquisitions/Mergers, Eyegate Pharmaceuticals, Valeant

Valeant and Eyegate Enter into Licensing Agreement for EyeGate II Delivery System and EGP-437 Combination Product

Valeant Pharmaceuticals International and EyeGate Pharmaceuticals announced that they have entered into an exclusive, worldwide licensing agreement through which EyeGate has granted a subsidiary of Va…

Read the full story

Thursday, February 16, 2017 | Acquisitions/Mergers, Retina

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Next-Generation Retinal Disease Therapy From University of Pittsburgh

BioTime announced that the company has obtained a worldwide license to intellectual property (IP) assets from University of Pittsburgh. The technology was developed in part in collaboration with BioTi…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Thursday, February 09, 2017 | Acquisitions/Mergers

Lions Eye Institute for Transplant & Research Doubles Its Size After Acquisition of International Sight Restoration

The Lions Eye Institute for Transplant & Research (LEITR) announced the acquisition of International Sight Restoration (ISR) in Tampa to double its size, creating one of the largest eye banks and …

Read the full story

Monday, February 06, 2017 | Acquisitions/Mergers, AMD

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Retinal Disease Therapy From University of Pittsburgh Medical Center

BioTime announced the acquisition of global rights to ophthalmology-related intellectual property assets from the University of Pittsburgh’s Medical Center (UPMC), via the school’s Innovat…

Read the full story

Thursday, January 26, 2017 | Acquisitions/Mergers, Johnson & Johnson Vision Care

Johnson & Johnson To Acquire Actelion For $30 Billion With Spin-Out Of New R&D Company

Johnson & Johnson, which in September agreed to acquire Abbott Medical Optics for $4.325 billion in cash, announced that it has agreed to acquired Actelion for $280 per share in cash, or $30 …

Read the full story

Tuesday, January 24, 2017 | Acquisitions/Mergers

Hilco Vision Announces the Acquisition of Croakies Inc.

Hilco Vision announced the acquisition of Croakies, the Wyoming-based originator of eyewear retainers and associated outdoor lifestyle accessories. Terms of the deal were not disclosed. "Hi…

Read the full story

Monday, January 16, 2017 | Acquisitions/Mergers

Essilor to Merge with Ray-Ban Maker Luxottica to Create $49 Billion Eyewear Giant

In a massive merger agreement that would reshape the eyewear industry, Luxottica Group, maker of Ray-Ban sunglasses, has agreed to a merger with French optical-lens maker Essilor International. Und…

Read the full story

Friday, January 13, 2017 | Acquisitions/Mergers, AMD, ForSight Vision

ForSight Vision 4 Announces Acquisition by Roche

ForSight Vision 4 announced that it has been acquired by Roche Holdings. The acquisition expands Roche's exclusive access to the ForSight Vision 4 PDS technology for long-acting delivery of therap…

Read the full story

Wednesday, December 21, 2016 | Acquisitions/Mergers, Allergan

Allergan to Acquire Acelity LifeCell Corporation for $2.9 Billion

Allergan and Acelity announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for $2.9 billion in cash. The…

Read the full story

Tuesday, December 20, 2016 | Acquisitions/Mergers, Novartis

Novartis Bolsters Ophthalmology Pipeline Through Acquisition of Encore Vision

Novartis announced that it has entered into a definitive agreement to acquire Encore Vision, a company focused on the development of a novel treatment in presbyopia. Terms of the deal were not disc…

Read the full story
Load More